Commission Implementing Regulation (EU) 2024/1749 of 24 June 2024 renewing the approval of the active substance metconazole as a candidate for substitution in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
| Amendments and corrections | |
|---|---|
| September 1, 2024 | Application - See Art 4 |
| July 15, 2024 | Entry into force - Date pub. +20 See Art 4 |
| Consolidated texts |
|---|